Guardian Pharmacy Services, Inc. $GRDN Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC increased its position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 65.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 336,701 shares of the company’s stock after acquiring an additional 133,715 shares during the period. Geode Capital Management LLC owned approximately 0.53% of Guardian Pharmacy Services worth $7,177,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also added to or reduced their stakes in the company. KLP Kapitalforvaltning AS purchased a new position in shares of Guardian Pharmacy Services in the second quarter worth about $75,000. Woodline Partners LP increased its holdings in Guardian Pharmacy Services by 1.5% in the 1st quarter. Woodline Partners LP now owns 421,203 shares of the company’s stock worth $8,955,000 after buying an additional 6,083 shares during the period. Peregrine Capital Management LLC raised its position in Guardian Pharmacy Services by 21.4% during the 2nd quarter. Peregrine Capital Management LLC now owns 214,379 shares of the company’s stock worth $4,568,000 after buying an additional 37,840 shares during the last quarter. TimesSquare Capital Management LLC acquired a new stake in Guardian Pharmacy Services during the 2nd quarter valued at approximately $17,351,000. Finally, CSM Advisors LLC purchased a new stake in shares of Guardian Pharmacy Services in the 2nd quarter valued at $2,052,000.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Wall Street Zen raised shares of Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Guardian Pharmacy Services in a research report on Monday. Truist Financial lifted their price objective on Guardian Pharmacy Services from $30.00 to $34.00 and gave the company a “buy” rating in a research note on Friday, November 14th. Finally, Oppenheimer started coverage on Guardian Pharmacy Services in a research note on Friday, October 10th. They issued an “outperform” rating and a $30.00 target price on the stock. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $30.67.

Guardian Pharmacy Services Stock Performance

Shares of NYSE GRDN opened at $29.71 on Friday. The company has a market capitalization of $1.88 billion, a PE ratio of 47.15 and a beta of 0.96. The company’s fifty day moving average price is $27.47 and its 200 day moving average price is $24.48. Guardian Pharmacy Services, Inc. has a 1 year low of $17.78 and a 1 year high of $37.43.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Monday, November 10th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.01. Guardian Pharmacy Services had a net margin of 2.90% and a return on equity of 30.29%. The business had revenue of $377.43 million during the quarter, compared to the consensus estimate of $381.16 million. On average, equities analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.